🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

And that's a wrap on the #DarkGenomeSymposium Session 2 presentations! Thanks to all the speakers for the great talks focused on non-coding RNA and epigenetics. #DGS2024 #DarkGenome

Up next at #DGS2024 is a panel discussion entitled “Beyond Coding: Unraveling the Regulation and Unconventional Functions of the #DarkGenome” featuring panelists from both industry and academia.

We got to hear two more short podium talks highlighting select #DGS2024 posters - which made us even more excited for this evening's poster session!

We’re so pleased to have more than 30 posters being presented at this year’s #DarkGenomeSymposium. The scientific advances and momentum in this space are awe-inspiring! #DGS2024 #DarkGenome

As we wrap up Day 1 of the #DarkGenomeSymposium, we want to say a hearty thank you to the Scientific Planning Committee, who put together a marvelous lineup of presenters, panelists, and posters representing a broad range of #DarkGenome topics. Thank you! #DGS2024

We’re proud to debut the first preclinical data of ROME’s LINE-1 RT inhibitors in #NeurodegenerativeDiseases at #DGS2024. These data in #ParkinsonsDisease will be presented at a short talk podium presentation later this morning. Learn more: rometx.com/press-releases… #DarkGenome

Day 2 of the 3rd annual #DarkGenomeSymposium is starting soon. Thank you NYU Langone Health for hosting us and providing the beautiful space for this event. #DGS2024

This morning’s #DGS2024 session is on the role of retroelements in #autoimmunity & #neurodegeneration, chaired by our CSO Heike Keilhack. Mounting scientific evidence suggests repetitive elements like LINE-1 are implicated in a range of autoimmune & neurodegenerative diseases.

"When we put this meeting together, we wanted to combine the basic science and translation -- developing therapies to ultimately benefit patients." -Heike Keilhack, Chief Scientific Officer, ROME #DGS2024 #TranslationalMedicine #DarkGenome

Fantastic presentations from the #DGS2024 Session 3 speakers elucidating the potential of #DarkGenome therapeutic approaches in a range of #AutoimmuneDiseases and #NeurodegenerativeDiseases. Thank you for sharing your research! #TranslationalMedicine #Lupus #Alzheimers

The next #DGS2024 panel will discuss the question: “Is the #DarkGenome an instigator or innocent bystander in autoimmunity and neurodegeneration?” Looking forward to further illumination of this next frontier in biology and its potential role in challenging diseases.

ROME’s poster highlighting our first data in #NeurodegenerativeDisease was selected for a #DGS2024 short talk, presented by Sarah Knutson, PhD. Learn more about the therapeutic potential of LINE-1 RT inhibitors in #ParkinsonsDisease: rometx.com/press-releases…

The fourth and final session of this year’s #DarkGenomeSymposium is kicking off now! Erwei Song, Daniel DeCarvalho, Abhijeet Pataskar, and session chair Sophie Papa will discuss immune-oncology and the #DarkGenome. #DGS2024

Thank you to the Session 4 #DGS2024 presenters for sharing your insights on the promise of #DarkGenome approaches in immuno-oncology! #TranslationalMedicine #CancerResearch #DarkGenomeSymposium

The final #DarkGenomeSymposium panel discussion will discuss: “Are Dark Antigens the Key to Off-The-Shelf Approaches for Next-Generation Immuno-Oncology Targets?” #DGS2024

We appreciated all of today’s short talks from selected #DGS2024 posters! We saw promising data in #ParkinsonsDisease, #RheumatoidArthritis, and #Cancer. Thanks to all presenters!

We’re closing out the 3rd annual #DarkGenomeSymposium with a keynote address: “Drugging the #DarkGenome: Lessons from HIV Reverse Trancriptase.” We’re honored to have Eddy Arnold, PhD, Distinguished Professor at Rutgers University, with us to share his insights! #DGS2024

Thank you to all speakers, panelists, poster presenters, in-person & virtual attendees, our co-hosts (Enara Bio, Nucleome Therapeutics & NYU Langone Health), and sponsors! We’re so proud of how far the #DarkGenome field has advanced, pioneering a new frontier in biology and medicine. #DGS2024

Wishing you a season of love & light! We’re proud of our 2024 accomplishments illuminating the #DarkGenome and advancing LINE-1 RT inhibition as a promising therapeutic approach for autoimmune & neurodegenerative diseases. Looking forward to further pioneering efforts in 2025!

We’re excited to share that we’ve launched our #Bluesky account! We look forward to being part of the growing science and biotech community on the Bluesky platform. Connect with us @rometx, and we’ll see many of you at #JPM25. #BioSky